Authors: Abbastabar, Maryam
Sarfi, Mohammad
Golestani, Abolfazl
Khalili, Ehsan
Title: lncRNA involvement in hepatocellular carcinoma metastasis and prognosis
Language (ISO): en
Abstract: Eukaryotic lncRNAs are RNA molecules defined to be greater than 200 bp in length that are not translated to a protein and operate through several mechanisms, including participating in chromatin remodeling and methylation, influencing the integrity and stability of proteins and complexes, or acting as a sponge for miRNA inhibition. A number of recent studies have concentrated on the relationship between long non-coding RNAs (lncRNAs) and cancer. Hepatocellular carcinoma (HCC) is the most prevalent histological type of liver tumors, accounting for about 80 % of the cases worldwide. Lack of proper molecular markers for diagnosis of HCC and treatment evaluation is a significant problem. Dysregulated expression of HCC-related lncRNAs such as MEG-3, MALAT1, HULC, HOTAIR, and H19 have been identified and closely related with tumorigenesis, metastasis, prognosis and diagnosis. In this review, we summarized recent highlighted functions and molecular mechanisms of the most extensively studied lncRNAs in the pathophysiology of hepatocellular carcinoma and their potential for serving as probable therapeutic targets.
Subject Headings: Hepatocellular carcinoma (HCC)
long non-coding RNA (lncRNAs)
Issue Date: 2018-09-04
Rights link:
Appears in Collections:Review Articles

Files in This Item:
File Description SizeFormat 
Khalili_04092018_proof.pdfDNB186.31 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons